drugset / Trial / NCT06119958
Drug-drug Interactions Between DWC202313 and DWC202314 in Healthy Subjects
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This is A two-arm, open-label, single-sequence, multiple oral dosings, crossover study to evaluate the safety and the pharmacokinetic interaction of DWC202313 and DWC202314 in healthy adult volunteers.
Timeline
- Start
- 2023-10-27
- Primary completion
- 2023-12
- Completion
- 2023-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DWC202313 | Unknown | — | Oral |
| Subject | DWC202314 | Unknown | — | Oral |
Indications
No indication recorded.